An easy-to-use neuromuscular blocking agent with rapid onset

• Patented non-cooling formulation1,2
• Needle-free handling
• Fastest onset of all non-depolarizing neuromuscular blocking agents3
• Intermediate duration of action4

References:
1. Rocuronium B. Braun Solution for Injection/Infusion 50mg/5ml Hong Kong prescribing information. B. Braun Medical (HK) Ltd. Version July 2020.
2. European Patent Office. European Patent Specification (EP2900216B1): Stabilized aqueous compositions of neuromuscular blocking agents.
3. Kim YB, et al. Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents. Korean J Anesthesiol. 2017 Oct; 70(5): 500–510.
4. Lien C, Eikermann M. (2019). 22 - Neuromuscular Blockers and Reversal Drugs. In H. Hemmings & T. Egan (Eds.), Pharmacology and Physiology Anesthesia (Second Edition). Elsevier. pp. 428-454.